ABSTRACT -Background -Nonalcoholic fatty liver disease (NAFLD) is the commonest hepatopathy worldwide. Objective -To investigate the correlations between NAFLD histopathological features and the levels of adipokines (adiponectin, leptin, and resistin) and circulating inflammatory markers (interleukin-6 [IL-6], interleukin-8 , tumor necrosis factor alpha [TNF-α], and C-reactive protein [CRP]). Methods -This is an exploratory cross-sectional study, which enrolled 19 women with obesity who underwent bariatric surgery. Biochemical characteristics evaluated included the levels of adiponectin, leptin, resistin, IL-6, IL-8, TNF-α, and CRP. NAFLD was assessed through histological examination of liver biopsies carried out during the surgical procedures. Results -The mean age of the study group was 37.3±8.2 years old; mean BMI was 36.2±2.5 kg/m 2 . Among individuals with liver fibrosis, the levels of IL-8 were significantly higher (24.4 ± 9.7 versus 12.7 ± 6.6; P=0.016726). The intensity of fibrosis presented a significant negative correlation with the levels of adiponectin (R= -0.49379; P=0.03166); i.e. the higher the levels of adiponectin, the lower the intensity of fibrosis. The intensity of steatohepatitis presented a significant negative correlation with the levels of adiponectin (R= -0.562321; P=0.01221); this means that the higher the levels of adiponectin, the lower the intensity of steatohepatitis. Conclusion -Adiponectin levels were inversely correlated with the severity of fibrosis and steatohepatitis, whereas IL-8 levels were higher in individuals with liver fibrosis among individuals with obesity and NAFLD undergoing bariatric surgery. The use of these markers to assess NAFLD may bring significant information within similar populations.
INTRODUCTION
Nonalcoholic fatty liver disease (NAFLD) is the commonest liver disease around the world, with a worldwide prevalence of 25%, according to a recent systematic review conducted by Younossi et al. Its prevalence has presented a significant rise over recent years, as a direct consequence of the obesity and diabetes epidemics, turning into a source of public health concern (1, 2) . Since it may present more aggressive phenotypes, which lead to severe forms as nonalcoholic steatohepatitis, cirrhosis, and even liver cancer, there are estimates that NAFLD will be the major indication for liver transplantation by 2030 in the United States (US) (3, 4) . The pathophysiology of NAFLD is multifactorial and involves several interconnected mechanisms, such as insulin resistance, lipototoxicity, imbalance of inflammatory mediators, endotoxinemia, among others (5) . The role of the metabolically active compounds secreted by the adipose tissue and collectively known as adipokines, as well as of many circulating inflammatory mediators and markers, appears to be significant on the pathogenesis of NAFLD, albeit poorly understood to date (6) (7) (8) .
Correlation between nonalcoholic fatty liver disease features and levels of adipokines and inflammatory cytokines among morbidly obese individuals
Adiponectin, leptin, and resistin are the most studies adipokines. Adiponectin is a hormone released by the adipose tissue, with anti-inflammatory properties such as inhibiting the effects of pro-inflammatory cytokines, mainly tumor necrosis factor alpha and interleukin-6; its circulating levels are usually lower in individuals with obesity (9) . Leptin is involved in the regulation of the circadian cycle and satiety in the central nervous system. Its levels are usually higher in individuals with obesity, although its effects are suppressed in this situation due to a phenomenon called leptin resistance; weight loss often leads to a decrease in its levels associated with an increase of its effects (10) . Resistin is a pro-inflammatory adipokine whose main properties are inducing inflammation and insulin resistance, angiogenesis, and proliferation of smooth muscle cells (11) . There are several substances produced by immune cells with active metabolic and immunomodulating functions; they are collectively named cytokines and are usually regarded as mediators and markers of the inflammatory process. Interleukin-6 [IL-6] is a glycoprotein released by a number of cells, mainly monocytes, macrophages, lymphocytes, fibroblasts, keratinocytes, endothelial cells, and some tumor cells; it is a regulator of the differentiation of CD4+ T-cells and its levels markedly increase in acute inflammation and mildly to moderately in chronic inflammatory conditions (12) . Interleukin-8 (IL-8) is a pro-inflammatory cytokine released by macrophages and epithelial cells whose main function is promoting chemotaxis of neutrophils and T-cells (13) . The tumor necrosis factor alpha (TNF-α) is a cytokine produced by macrophages in response to endotoxinemia, inflammation and cancer; higher levels are usually associated with the acute inflammatory response, but are also linked to obesity (14) . The C-reactive protein (CRP) is an acute-phase protein secreted by the liver that increases following IL-6 secretion by macrophages and T-cells; its levels are also mildly elevated in chronic inflammation (15) . Since adipokines, cytokines, and inflammatory markers may present clinical relevance to be used targets for the research of novel therapies, diagnosis methods and assessment of severity of NAFLD, the evaluation of their correlations with the histological abnormalities of this disease presents a significant importance.
This study aims to investigate the correlations between NAFLD histopathological features and the levels of adipokines (adiponectin, leptin, and resistin) and circulating inflammatory markers (IL-6, IL-8, TNF-α, and CRP).
METHODS
This is an exploratory cross-sectional study, which enrolled 19 women with obesity who underwent bariatric surgery at a university hospital from January through December 2015. This study underwent evaluation and was approved by the institutional Ethics Review Board under the reference UNICAMP/289.425. Bariatric surgery was indicated according to the National Institutes of Health Consensus Statement criteria (16) . The surgical technique used in all of the individuals was the Roux-en-Y gastric bypass (RYGB). Surgery was indicated for individuals who presented obesity for at least five years, with at least two unsuccessful attempts to conservative treatment, with a body mass index (BMI) equal or above 40 kg/m 2 , or equal or above 35 kg/m 2 associated with obesity-related comorbidities. The inclusion criteria were: women aged from 18 to 65 years old, which underwent RYGB. The exclusion criteria were: subjects who belonged to vulnerable groups (mentally ill, institutionalized or aged below 18 years old); recent or previous abuse of alcohol; antecedents of viral acute or chronic hepatitis; serologic abnormalities regarding hepatitis B or C virus; and previous bile duct obstruction.
All subjects who undergo bariatric surgery at this institution take part in a preoperative weight loss program which lasts 4 to 12 weeks and is comprehended by weekly consultations carried out by a multidisciplinary team. Individuals undergo surgery once a minimal 10% preoperative weight loss is achieved or since the minimal body mass index (BMI) of 35 kg/m 2 for subjects with obesity-related morbidities or 40 kg/m 2 for those free of comorbidities is reached (17) . No liquid or very low-calorie diet was prescribed in the immediate preoperative period to specifically reduce liver fat volume. All the lab examinations were collected on the day immediately prior to the surgical procedure.
Main characteristics regarding demographics and anthropometric parameters were assessed. Biochemical characteristics evaluated included the levels of adiponectin, leptin, resistin, IL-6, IL-8, TNF-A, and CRP, which were determined in the plasma by means of Western-blot analysis (SpectraMax i3, Molecular Devices,
CA, EUA) at a 540-nm-wavelength. These laboratory assays were collected the day prior to surgery in a fasting state.
NAFLD was assessed through histological examination of liver biopsies carried out during the surgical procedures. All the histological examinations were performed by the same pathologist. Liver abnormalities were classified into three categories: 1) steatosis; 2) fibrosis; 3) steatohepatitis. Each category was divided accordingly as absent or present. The severity of each abnormality was stratified into four categories: absent (0), mild (1), moderate (2), or severe (3).
Statistical analysis
Data were expressed as means ± standard deviation. For comparison of proportions, chi-square and Fisher's exact tests were carried out. To compare continuous measures between independent or correlated groups, the Mann-Whitney test was used. Spearman's correlation coefficients (values of R) were calculated to assess the association between variables and the outcomes analyzed. The values of R vary from -1 to 1; values next to the extremities signal negative or positive correlations, respectively. The significance level adopted was 5% (P-value <0.05). For the execution of analysis, it was used Statistic Analysis System (SAS) software for Windows version 9.2.
RESULTS
The mean age of the study group was 37.3±8.2 years old; mean BMI was 36.2±2.5 kg/m 2 . All of the studied individuals presented mild steatosis at the liver biopsy examination. In relation to fibrosis, 15.8% presented no fibrosis, 63.1% mild fibrosis, and 21.1% moderate fibrosis. Regarding liver inflammatorty activity, 36.8% presented no steatohepatitis, 52.6% mild steatohepatitis, and 10.6% moderate steatohepatitis. The main demographic, anthropometric and the distribution of NAFLD features are presented in TABLE 1. 
DISCUSSION
The interplay between the liver metabolism and circulating levels of active substances with pro or anti-inflammatory properties is a complex pathophysiological process which is not completely understood. However, due to obesity and fatty liver epidemics, the analysis of the role of these compounds presents a great significance as a way to gain insight into the mechanisms of chronic liver injury and plan therapies targeting these molecules or, at least, their use as markers of severity of disease.
The current study showed significant negative correlations between the levels of adiponectin and the severity of both liver fibrosis and steatohepatitis, signaling a protective effect of adiponectin in The intensity of fibrosis presented a significant negative correlation with the levels of adiponectin (R= -0.49379; P=0.03166); this means that the higher the levels of adiponectin, the lower the intensity of fibrosis. FIGURE 1 presents graphical representations of the correlation analysis of each variable evaluated with the severity of fibrosis and the respective correlation coefficients and values of P. Similarly, the intensity of steatohepatitis presented a significant negative correlation with the levels of adiponectin (R= -0.562321; P=0.01221); this means that the higher the levels of adiponectin, the lower the intensity of steatohepatitis. None of the other evaluated variables presented significant correlations with the intensities of both fibrosis and steatohepatitis. FIGURE 2 presents graphical representations of the correlation analysis of each variable evaluated with the severity of steatohepatitis and the respective correlation coefficients and values of P.
FIGURE 1.
Correlations between adipokine/cytokine profiles and severity of fibrosis. IL-6: interleukin-6; IL=8: interleukin-8; TNF-α: tumor necrosis factor alpha; CRP: C-reactive protein; R: coefficient of correlation; P: value of P.
FIGURE 2.
Correlations between adipokine/cytokine profiles and severity of steatohepatitis. IL-6: interleukin-6; IL=8: interleukin-8; TNF-α: tumor necrosis factor alpha; CRP: C-reactive protein; R: coefficient of correlation; P: value of P. regard to the progression of NAFLD to more aggressive forms. This role may be potentially linked to the anti-inflammatory properties of adiponectin, as well as its insulin sensitizing effect. Both effects are likely to act conjointly to, at least, stabilize the liver injury in the context of NAFLD. The relationship between adiponectin and hepatoprotection has been previously observed in the literature (18) (19) (20) (21) . Since bariatric surgery leads to increases in the levels of adiponectin (22) (23) (24) (25) , it is reasonable to suppose that this mechanism is involved to some degree in the significant improvement of NAFLD reported after surgery (26) (27) (28) (29) . There is evidence that leptin levels are associated with liver disease (30) (31) (32) ; it is possible that the present study did not show significant correlations because all of the studied individuals presented obesity and thus tended to present high levels. The role of resistin in the development and progression of NAFLD is not so well established and the previous available evidence showed mixed results, with some authors reporting a significant association with NAFLD (33) (34) (35) , and others demonstrating no differences (36) (37) (38) . D'Incao et al. have observed that leptin levels were inversely correlated with the degree of steatosis, and also that resistin levels were inversely correlated with fibrosis stages (18) . Higher levels of IL-8 among individuals with liver fibrosis were also observed in the present study. Previous studies have demonstrated that IL-8 is strongly activated in chronic liver disease, thus likely contributing to liver inflammation; Zimmerman et al. (39) suggested a possible role of IL-8 for recruitment and activation of hepatic macrophages. The increased levels of IL-8 among individuals with NAFLD compared to healthy controls have also been demonstrated by Jarrar et al. (40) and Hasanaliyeva et al. (41) . The latter study pointed out the IL-8 levels were also independently associated with fibrosis among individuals with NAFLD. There is scarce evidence on the influence of bariatric surgery on IL-8 levels; Klein et al. (42) observed a significant decrease in its levels, thus this may also be involved in the improvement of NAFLD after surgery.
Although CRP, TNF-α, and IL-6 did not differ statistically among the studied individuals, there are previous evidence of their significant influence on the NAFLD pathophysiology (43) (44) (45) (46) . The lack of significance in regards to these markers in the present study may be caused by the small number of individuals analyzed, or by the selection bias due to the high frequency of NAFLD within this population.
This study has some limitations that should be taken into account. Firstly, it was performed in a small patient population; this occurs primarily due to the high costs of the assays utilized in this study. Furthermore, there was not a control group with healthy individuals and all the studied individuals presented some degree of NAFLD, facts that limit a complete explanation of the findings and further extrapolation. The major caveat of this approach is that it is not possible to fully determine which features should certainly be ascribed to which of the three modalities of liver disease considered, as they overlap in the analysis. Finally, the complete inflammatory panel involves a number of mediators which were not analyzed in this study; since there is a complex interplay among these compounds, it may also avoid ultimate conclusions. Despite these caveats, the results of the present study permit significant insights in regards to the progression of liver disease among individuals with obesity and reinforce the possibility of using some of these molecules as markers for diagnosis and following, or even targets for potential therapies.
CONCLUSION
Adiponectin levels were inversely correlated with the severity of fibrosis and steatohepatitis, whereas IL-8 levels were higher in individuals with liver fibrosis among individuals with obesity and NAFLD undergoing bariatric surgery.
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